These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38941087)

  • 1. Quantifying Industry Spending on Promotional Events Using Open Payments Data.
    Grundy Q; Held F; MacIsaac M; Baugh CM; Campbell EG; Bero L
    JAMA Health Forum; 2024 Jun; 5(6):e241581. PubMed ID: 38941087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical Marketing in the United States, 1997-2016.
    Schwartz LM; Woloshin S
    JAMA; 2019 Jan; 321(1):80-96. PubMed ID: 30620375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical industry-sponsored meals are associated with increased prescriptions and Medicare spending for dupilumab among dermatologists in the United States.
    Murayama A
    J Eval Clin Pract; 2024 Apr; 30(3):435-439. PubMed ID: 38149692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin.
    Hartung DM; Johnston K; Cohen DM; Nguyen T; Deodhar A; Bourdette DN
    JAMA Netw Open; 2018 Jun; 1(2):e180482. PubMed ID: 30646086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Advanced Practice Nurses Receiving Top Industry Payments and Their Practice Settings: a Cross-sectional Study.
    Grundy Q; Held F; Hart D; Baugh CM; Ladd E; Campbell E; Bero L
    J Gen Intern Med; 2024 May; 39(7):1142-1148. PubMed ID: 37962732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and over-active bladder syndrome? An Australian cohort study.
    Mintzes B; Swandari S; Fabbri A; Grundy Q; Moynihan R; Bero L
    BMJ Open; 2018 Feb; 8(2):e019027. PubMed ID: 29440213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Payments From Pharmaceutical Companies to Authors Involved in the Valsartan Scandal in Japan.
    Sawano T; Ozaki A; Saito H; Shimada Y; Tanimoto T
    JAMA Netw Open; 2019 May; 2(5):e193817. PubMed ID: 31099864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Industry Payment to Vascular Neurologists: A 6-Year Analysis of the Open Payments Program From 2013 Through 2018.
    Nalleballe K; Sheng S; Li C; Mahashabde R; Annapureddy AR; Mudassar K; Pothineni K; Veerapaneni P; Harada Y; Chilkulwar A; Ranabothu S; Brown A; Kapoor N; Onteddu S
    Stroke; 2020 Apr; 51(4):1339-1343. PubMed ID: 32078482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia.
    Fabbri A; Grundy Q; Mintzes B; Swandari S; Moynihan R; Walkom E; Bero LA
    BMJ Open; 2017 Jun; 7(6):e016701. PubMed ID: 28667226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Psychiatrist-Industry Financial Relationship: Insight from the Open Payment Data of Centers for Medicare and Medicaid Services.
    Rhee TG; Wilkinson ST
    Adm Policy Ment Health; 2020 Jul; 47(4):526-530. PubMed ID: 31916072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
    DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA
    JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of Industry Payments to Radiation Oncologists in 2014 Using the Centers for Medicare and Medicaid Services Open Payments Database.
    Jairam V; Yu JB
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):19-26. PubMed ID: 26547386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Industry Payments to US Advanced Practice Clinicians in 2021.
    Singh A; Hyman MJ; Modi PK
    JAMA Netw Open; 2022 Nov; 5(11):e2242869. PubMed ID: 36399340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan.
    Saito H; Ozaki A; Sawano T; Shimada Y; Tanimoto T
    JAMA Netw Open; 2019 Apr; 2(4):e192834. PubMed ID: 31026027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Open Payments Receipts Among Surgical Faculty at a Large Academic Institution.
    Fazendin JM; Corey BL; Heslin MJ; Chen H
    J Surg Res; 2019 Dec; 244():599-603. PubMed ID: 31536845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Financial relationships between neurologists and industry: The 2015 Open Payments database.
    Ahlawat A; Narayanaswami P
    Neurology; 2018 Jun; 90(23):1063-1070. PubMed ID: 29728521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015.
    Ozieranski P; Csanadi M; Rickard E; Tchilingirian J; Mulinari S
    JAMA Netw Open; 2019 Jun; 2(6):e196253. PubMed ID: 31225896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Industry-Dermatologist Financial Relationship: Insight From the Open Payment Data.
    Feng H; Wu P; Leger M
    JAMA Dermatol; 2016 Dec; 152(12):1307-1313. PubMed ID: 27706478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics Of Biomedical Industry Payments To Teaching Hospitals.
    Anderson TS; Gellad WF; Good CB
    Health Aff (Millwood); 2020 Sep; 39(9):1583-1591. PubMed ID: 32897778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician Payments from Pharmaceutical Companies Related to Cancer Drugs.
    Mitchell AP; Mishra Meza A; Trivedi NU; Bach PB; Gönen M
    Oncologist; 2022 Oct; 27(10):857-863. PubMed ID: 35946837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.